Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study

Open access
van Nieuwkoop, Cees, Bonten, Tobias N, van't Wout, Jan W, Kuijper, Ed J, Groeneveld, Geert H, Becker, Martin J, Koster, Ted, Wattel-Louis, G Hanke, Delfos, Nathalie M, Ablij, Hans C, Leyten, Eliane MS, van Dissel, Jaap T · 2010 · Critical Care

Abstract

Introduction: Guidelines recommend that two blood cultures be performed in patients with febrile urinary tract infection (UTI), to detect bacteremia and help diagnose urosepsis. The usefulness and cost-effectiveness of this practice have been criticized. This study aimed to evaluate clinical characteristics and the biomarker procalcitonin (PCT) as an aid in predicting bacteremia. Methods: A prospective observational multicenter cohort study included consecutive adults with febrile UTI in 35 primary care units and 8 emergency departments of 7 regional hospitals. Clinical and microbiological data were collected and PCT and time to positivity (TTP) of blood culture were measured. Results: Of 581 evaluable patients, 136 (23%) had bacteremia. The median age was 66 years (interquartile range 46 to 78 years) and 219 (38%) were male. We evaluated three different models: a clinical model including seven bed-side characteristics, the clinical model plus PCT, and a PCT only model. The diagnostic abilities of these models as reflected by area under the curve of the receiver operating characteristic were 0.71 (95% confidence interval (CI): 0.66 to 0.76), 0.79 (95% CI: 0.75 to 0.83) and 0.73 (95% CI: 0.68 to 0.77) respectively. Calculating corresponding sensitivity and specificity for the presence of bacteremia after each step of adding a significant predictor in the model yielded that the PCT > 0.25 μg/l only model had the best diagnostic performance (sensitivity 0.95; 95% CI: 0.89 to 0.98, specificity 0.50; 95% CI: 0.46 to 0.55). Using PCT as a single decision tool, this would result in 40% fewer blood cultures being taken, while still identifying 94 to 99% of patients with bacteremia. The TTP of E. coli positive blood cultures was linearly correlated with the PCT log value; the higher the PCT the shorter the TTP (R 2 = 0.278, P = 0.007). Conclusions: PCT accurately predicts the presence of bacteremia and bacterial load in patients with febrile UTI. This may be a helpful biomarker to limit use of blood culture resources.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc9328

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 32

  1. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB: Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15: 148-151. 10.1016/S0735-6757(97)90087-5 · DOI
  2. Kunin CM: Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med 2003, 163: 2393-2394. 10.1001/archinte.163.19.2393-b · doi:10.1001/archinte.163.19.2393-b
  3. Brown P, Ki M, Foxman B: Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 2005, 23: 1123-1142. 10.2165/00019053-200523110-00005 · DOI
  4. Foxman B, Klemstine KL, Brown PD: Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003, 13: 144-150. 10.1016/S1047-2797(02)00272-7 · DOI · Paper page
  5. Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603 · doi:10.1007/bf01704603
  6. Leibovici L, Greenshtain S, Cohen O, Wysenbeek AJ: Toward improved empiric management of moderate to severe urinary tract infections. Arch Intern Med 1992, 152: 2481-2486. 10.1001/archinte.152.12.2481 · DOI
  7. Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM: The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006, 332: 175-180. 10.1097/00000441-200610000-00004 · DOI
  8. Velasco M, Martínez JA, Moreno-Martínez A, Horcajada JP, Ruiz J, Barranco M, Almela M, Vila J, Mensa J: Blood cultures for women with uncomplicated acute pyelonephritis: are they necessary? Clin Infect Dis 2003, 37: 1127-1130. 10.1086/378291 · DOI
  9. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R: Are blood cultures necessary in the management of women with complicated pyelonephritis? J Infect 2006, 53: 235-240. 10.1016/j.jinf.2005.12.005 · doi:10.1016/j.jinf.2005.12.005
  10. van Nieuwkoop C, van't Wout JW, Spelt IC, Becker M, Kuijper EJ, Blom JW, Assendelft WJ, van Dissel JT: Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment. J Infect 2010, 60: 114-121. 10.1016/j.jinf.2009.11.008 · DOI
  11. Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM: Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis 2007, 26: 349-352. 10.1007/s10096-007-0287-3 · DOI
  12. Jerkeman M, Braconier JH: Bacteremic and non-bacteremic febrile urinary tract infection--a review of 168 hospital-treated patients. Infection 1992, 20: 143-145. 10.1007/BF01704603 · doi:10.1007/bf01704603
  13. Lee A, Mirrett S, Reller LB, Weinstein MP: Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol 2007, 45: 3546-3548. 10.1128/JCM.01555-07 · DOI · Paper page
  14. Gander RM, Byrd L, DeCrescenzo M, Hirany S, Bowen M, Baughman J: Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009, 47: 1021-1024. 10.1128/JCM.02162-08 · DOI · Paper page
  15. McCaig LF, McDonald LC, Cohen AL, Kuehnert MJ: Increasing blood culture use at US hospital emergency department visits, 2001 to 2004. Ann Emerg Med 2007, 50: 42-48. 48.e1-2 10.1016/j.annemergmed.2006.12.002 · doi:10.1016/j.annemergmed.2006.12.002
  16. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, et al.: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41 · DOI · Paper page
  17. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA: Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50: 34-41. 10.1016/j.annemergmed.2006.10.020 · DOI · Paper page
  18. van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, Westendorp RG, van Dissel JT: Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000, 31: 1343-1348. 10.1086/317480 · DOI
  19. Martínez JA, Pozo L, Almela M, Marco F, Soriano A, López F, Balasso V, Aguilar J, Mensa J: Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 2007, 13: 709-716. 10.1111/j.1469-0691.2007.01736.x · doi:10.1111/j.1469-0691.2007.01736.x
  20. van Nieuwkoop C, Bonten TN, Wout JW, Becker MJ, Groeneveld GH, Jansen CL, van der Vorm ER, Ijzerman EP, Rothbarth PH, Termeer-Veringa EM, Kuijper EJ, van Dissel JT: Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis 2010, 50: e69-e72. 10.1086/652657 · DOI
  21. Muller B, Schuetz P, Trampuz A: Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007, 30: S16-23. 10.1016/j.ijantimicag.2007.06.032 · doi:10.1016/j.ijantimicag.2007.06.032
  22. Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, May T, Hoen B: Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002, 35: 156-161. 10.1086/341023 · DOI · Paper page
  23. Liaudat S, Dayer E, Praz G, Bille J, Troillet N: Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20: 524-527. 10.1007/s100960100548 · doi:10.1007/s100960100548
  24. Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P, ProHOSP Study Group: Procalcitonin levels Predict Bacteremia in Patients with community-acquired Pneumonia: A prospective cohort trial. Chest 2010, 138: 121-129. · DOI · Paper page
  25. Fontanarosa PB, Kaeberlein FJ, Gerson LW, Thomson RB: Difficulty in predicting bacteremia in elderly emergency patients. Ann Emerg Med 1992, 21: 842-848. 10.1016/S0196-0644(05)81032-7 · DOI
  26. Schuetz P, Mueller B, Trampuz A: Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007, 35: 352-355. 10.1007/s15010-007-7065-0 · doi:10.1007/s15010-007-7065-0
  27. Blot F, Schmidt E, Nitenberg G, Tancrède C, Leclercq B, Laplanche A, Andremont A: Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998, 36: 105-109. · DOI · Paper page
  28. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, ProHOSP Study Group: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302: 1059-1066. 10.1001/jama.2009.1297 · DOI · Paper page
  29. Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC, GenIMS Investigators: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008, 52: 48-58. 10.1016/j.annemergmed.2008.01.003 · DOI · Paper page
  30. Claessens YE, Schmidt J, Batard E, Grabar S, Jegou D, Hausfater P, Kierzek G, Guérin S, Pourriat JL, Dhainaut JF, Ginsburg C, BIS Study Group: Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2010, 16: 753-760. · DOI
  31. Lemiale V, Renaud B, Moutereau S, N'Gako A, Salloum M, Calmettes MJ, Hervé J, Boraud C, Santin A, Grégo JC, Braconnier F, Roupie E: A single procalcitonin level does not predict adverse outcomes of women with pyelonephritis. Eur Urol 2007, 51: 1394-1401. 10.1016/j.eururo.2006.12.018 · DOI
  32. Schuetz P, Christ-Crain M, Huber AR, Muller B: Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays. Clin Biochem 2010, 43: 341-344. 10.1016/j.clinbiochem.2009.08.029 · DOI

Cited by

See all 193

Metadata

Authors
van Nieuwkoop, C., Bonten, T. N., van't Wout, J. W., Kuijper, E. J., Groeneveld, G. H., Becker, M. J., Koster, T., Wattel-Louis, G. H., Delfos, N. M., Ablij, H. C., Leyten, E. M., & van Dissel, J. T.
Venue
Critical Care
Published
2010-11-17
Volume
14
Issue
6
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2125056753
Cited by
193
References
2
FWCI
5.66
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. https://app.cochat.ai/papers/10.1186/cc9328
The paper
van Nieuwkoop, C., Bonten, T. N., van't Wout, J. W., Kuijper, E. J., Groeneveld, G. H., Becker, M. J., Koster, T., Wattel-Louis, G. H., Delfos, N. M., Ablij, H. C., Leyten, E. M., & van Dissel, J. T. (2010). Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Critical Care. https://doi.org/10.1186/cc9328

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.